A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial
Abstract
1. Introduction
2. Materials and Methods
2.1. Recruitment Strategies
2.2. Randomization Procedures
2.3. Inclusion and Exclusion Criteria
2.4. PNF+ Group
2.5. Healthy Diet (AC) Group
2.6. Text Platform
2.7. Outcome Measures
2.7.1. Feasibility
2.7.2. Acceptability
2.7.3. Exploratory Outcomes
2.8. Sample Size Consideration and Statistical Analysis
3. Results
3.1. Recruitment and Retention
3.2. Demographics
3.3. Feasibility
3.4. Acceptability
3.4.1. Severe or Very Severe Adverse Events (A/E)
3.4.2. Client Satisfaction
3.4.3. Post-Intervention Interviews
3.5. Exploratory Outcomes
FACIT-F, FACT-P, Body Weight and BMI
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| PCa | Prostate Cancer |
| ADT | Androgen Deprivation Therapy |
| QOL | Quality of Life |
| PCSM | Prostate Cancer Specific Mortality |
| DALYS | Disability-adjusted Life Years |
| PNF | Prolonged Nightly Fasting |
| RCT | Randomized Controlled Trial |
| IGF-1 | Insulin-like Growth Factor |
| CVD | Cardiovascular Disease |
| EMR | Electronic Medical Records |
| GNRH | Gonadotropin Releasing Hormone |
| BMI | Body Mass Index |
| CSQ-8 | Client Satisfaction Questionnaire-8 Item |
| A/E | Adverse Events |
| FACIT-F | Functional Assessment of Chronic Illness Therapy-Fatigue |
| FACT-P | Functional Assessment of Cancer Therapy-Prostate Cancer |
References
- Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 2016, 66, 7–30. [Google Scholar] [CrossRef]
- Bourke, L.; Doll, H.; Crank, H.; Daley, A.; Rosario, D.; Saxton, J.M. Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: A feasibility study. Cancer Epidemiol. Biomark. Prev. 2011, 20, 647–657. [Google Scholar] [CrossRef]
- Troeschel, A.N.; Hartman, T.J.; Jacobs, E.J.; Stevens, V.L.; Gansler, T.; Flanders, W.D.; McCullough, L.E.; Wang, Y. Postdiagnosis body mass index, weight change, and mortality from prostate cancer, cardiovascular disease, and all cause among survivors of nonmetastatic prostate cancer. J. Clin. Oncol. 2020, 38, 2018–2027. [Google Scholar] [CrossRef]
- Xie, J.; Zhao, J. The global burden of cancer attributable to dietary factors from 1990 to 2019. Public Health Nutr. 2025, 29, 1–23. [Google Scholar] [CrossRef]
- O’Donnell, E.; Shapiro, Y.; Comander, A.; Isakoff, S.; Moy, B.; Spring, L.; Wander, S.; Kuter, I.; Shin, J.; Specht, M.; et al. Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast). Breast Cancer Res. Treat. 2022, 193, 579–587. [Google Scholar] [CrossRef]
- Zhang, J.; Deng, Y.; Khoo, B.L. Fasting to enhance Cancer treatment in models: The next steps. J. Biomed. Sci. 2020, 27, 58. [Google Scholar] [CrossRef]
- Faris, M.E.; Alkawamleh, D.H.; Madkour, M.I. Unraveling the impact of intermittent fasting in cancer prevention, mitigation, and treatment: A narrative review. J. Nutr. Oncol. 2025, 10, 29–39. [Google Scholar] [CrossRef]
- Shimi, G. Dietary approaches for controlling cancer by limiting the Warburg effect: A review. Nutr. Rev. 2024, 82, 1281–1291. [Google Scholar] [CrossRef] [PubMed]
- Hatori, M.; Vollmers, C.; Zarrinpar, A.; DiTacchio, L.; Bushong, E.A.; Gill, S.; Leblanc, M.; Chaix, A.; Joens, M.; Fitzpatrick, J.A.; et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012, 15, 848–860. [Google Scholar] [CrossRef]
- Marinac, C.R.; Nelson, S.H.; Breen, C.I.; Hartman, S.J.; Natarajan, L.; Pierce, J.P.; Flatt, S.W.; Sears, D.D.; Patterson, R.E. Prolonged Nightly Fasting and Breast Cancer Prognosis. JAMA Oncol. 2016, 2, 1049–1055. [Google Scholar] [CrossRef] [PubMed]
- Valdemarin, F.; Caffa, I.; Persia, A.; Cremonini, A.L.; Ferrando, L.; Tagliafico, L.; Tagliafico, A.; Guijarro, A.; Carbone, F.; Ministrini, S.; et al. Safety and feasibility of fasting-mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment. Cancers 2021, 13, 4013. [Google Scholar] [CrossRef]
- Vega, C.; Barnafi, E.; Sánchez, C.; Acevedo, F.; Walbaum, B.; Parada, A.; Rivas, N.; Merino, T. Calorie restriction and time-restricted feeding: Effective interventions in overweight or obese patients undergoing radiotherapy treatment with curative intent for cancer. Nutrients 2024, 16, 477. [Google Scholar] [CrossRef]
- Kleckner, A.S.; Altman, B.J.; Reschke, J.E.; Kleckner, I.R.; Culakova, E.; Dunne, R.F.; Mustian, K.M.; Peppone, L.J. Time-restricted eating to address cancer-related fatigue among cancer survivors: A single-arm pilot study. J. Integr. Oncol. 2022, 11, 379. [Google Scholar]
- Phillips, N.E.; Mareschal, J.; Schwab, N.; Manoogian, E.N.C.; Borloz, S.; Ostinelli, G.; Gauthier-Jaques, A.; Umwali, S.; Gonzalez Rodriguez, E.; Aeberli, D.; et al. The effects of time-restricted eating versus standard dietary advice on weight, metabolic health and the consumption of processed food: A pragmatic randomised controlled trial in community-based adults. Nutrients 2021, 13, 1042. [Google Scholar] [CrossRef]
- Kirkham, A.A.; Ford, K.L.; Ramos Da Silva, B.; Topolnyski, J.; Prado, C.M.; Joy, A.A.; Paterson, D.I.; Boulé, N.; Pituskin, E.; Haykowsky, M.J.; et al. Implementation of weekday time-restricted eating to improve metabolic health in breast cancer survivors with overweight/obesity. Obesity 2023, 31, 150–160. [Google Scholar] [CrossRef]
- Lin, C.-L.; Huang, L.-C.; Chang, Y.-T.; Chen, R.-Y.; Yang, S.-H. Effectiveness of health coaching in diabetes control and lifestyle improvement: A randomized-controlled trial. Nutrients 2021, 13, 3878. [Google Scholar] [CrossRef] [PubMed]
- Wolever, R.Q.; Simmons, L.A.; Sforzo, G.A.; Dill, D.; Kaye, M.; Bechard, E.M.; Southard, M.E.; Kennedy, M.; Vosloo, J.; Yang, N. A systematic review of the literature on health and wellness coaching: Defining a key behavioral intervention in healthcare. Glob. Adv. Health Med. 2013, 2, 38–57. [Google Scholar] [CrossRef] [PubMed]
- Larsen, D.L.; Attkisson, C.C.; Hargreaves, W.A.; Nguyen, T.D. Assessment of client/patient satisfaction: Development of a general scale. Eval. Program Plan. 1979, 2, 197–207. [Google Scholar] [CrossRef] [PubMed]
- Cella, D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin. Hematol. 1997, 34, 13–19. [Google Scholar]
- Esper, P.; Mo, F.; Chodak, G.; Sinner, M.; Cella, D.; Pienta, K. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997, 50, 920–928. [Google Scholar] [CrossRef]
- Joseph, C.; John, W.; Ken, F. Chapter 14—Adherence and Illness Perceptions in Patients with CKD and ESRD. In Psychosocial Aspects of Chronic Kidney Disease; Cukor, D., Cohen, S.D., Kimmel, P.L., Eds.; Academic Press: Cambridge, MA, USA, 2021; pp. 297–309. [Google Scholar]
- Meyerowitz-Katz, G.; Ravi, S.; Arnolda, L.; Feng, X.; Maberly, G.; Astell-Burt, T. Rates of Attrition and Dropout in App-Based Interventions for Chronic Disease: Systematic Review and Meta-Analysis. J. Med. Internet Res. 2020, 22, e20283. [Google Scholar] [CrossRef] [PubMed]
- Ames, H.M.; Glenton, C.; Lewin, S.; Tamrat, T.; Akama, E.; Leon, N. Clients’ perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive, maternal, newborn, child, and adolescent health: A qualitative evidence synthesis. Cochrane Database Syst. Rev. 2019, 10, Cd013447. [Google Scholar] [CrossRef] [PubMed]
- Spark, L.C.; Fjeldsoe, B.S.; Eakin, E.G.; Reeves, M.M. Efficacy of a Text Message-Delivered Extended Contact Intervention on Maintenance of Weight Loss, Physical Activity, and Dietary Behavior Change. JMIR mHealth uHealth 2015, 3, e88. [Google Scholar] [CrossRef] [PubMed]
- Coa, K.; Smith, K.; Klassen, A.; Thorpe, R.; Caulfield, L. Exploring Important Influences on the Healthfulness of Prostate Cancer Survivors’ Diets. Qual. Health Res. 2015, 25, 857–870. [Google Scholar] [CrossRef]




| Demographic Variable | All (n = 40) | PNF+ (n = 27) | Healthy Diet (n = 13) | p-Value |
|---|---|---|---|---|
| Mean Age & SD | 69.5 ± 7.6 | 69.0 ± 6.3 | 70.3 ± 10.0 | 0.68 |
| Race | % | % | % | 0.86 |
| Black or African American | 32.5% | 33.3% | 30.8% | |
| White | 62.5% | 63.0% | 61.5% | |
| Other | 5.0% | 3.7% | 7.7% | |
| Education | % | % | % | 1.00 |
| College Graduate or Post-College | 47.5% | 48.1% | 46.2% | |
| Below College | 52.5% | 51.9% | 53.8% | |
| Household Income | % | % | % | 0.02 |
| $0–$15,000 | 12.5% | 14.8% | 7.7% | |
| $15,001–$60,000 | 40.0% | 40.7% | 38.5% | |
| $60,001–$75,001 | 10.0% | 0.0% | 30.8% | |
| $75,001+ | 37.5% | 44.4% | 23.1% | |
| Mean Medication Duration in Days | 403.9 ± 590.0 | 368.0 ± 604.8 | 474.9 ± 563.0 | 0.61 |
| Hormone Therapy Medication | % | % | % | N/A |
| LHRH Agonist | 82.5% | 85.2% | 76.9% | |
| LHRH Antagonist | 10.0% | 11.1% | 7.7% | |
| Androgen Receptor Inhibitor | 27.5% | 29.6% | 23.1% | |
| Androgen Synthesis Inhibitor | 15.0% | 11.1% | 23.1% | |
| Bone Modifying Agent | 5.0% | 7.4% | 0.0% |
| Health Coaching Adherence | PNF Window Adherence | Picture Response Adherence | ||||
|---|---|---|---|---|---|---|
| % of Sample | Mean (%) | % of Sample | Mean (%) | % of Sample | Mean (%) | |
| Low (0–60%) | 13% | 42% | 25% | 35% | 8% | 55% |
| Moderate (61–80%) | 29% | 64% | 46% | 71% | 17% | 73% |
| High (81–100%) | 58% | 89% | 29% | 89% | 75% | 92% |
| Total | 100% | 82% | 100% | 69% | 100% | 85% |
| Domain | Category | Barriers/Facilitator | Sample Participants Quotes |
|---|---|---|---|
| Capability | Psychological capability | Barrier | “I just couldn’t adjust to the fasting period… I couldn’t wait until 9 o’clock to eat breakfast.” “Was not fully aware of the purpose at the beginning.” |
| Facilitator | “It helps me make more conscious decisions and be aware of how I feel when I eat.” “Will eat more protein for breakfast, I am more conscious of the diet.” | ||
| Practical capability | Barriers | “I forgot to send pictures most of the times.” | |
| Opportunity | Practical opportunity | Barrier | “It is difficult to do, especially with business travel.” “I don’t finish work until 6:30 p.m.” “If you are on a rigid work schedule, I think it would work.” |
| Facilitator | “I am retired so the schedule suits me.” “Being out of the house and being active helps.” “I enjoy cooking… I like the schedule.” | ||
| Social opportunity | Barrier | “If I radically alter mealtimes, it would have caused disruption.” “I do not do the cooking; my wife does.” “We have this rule that no phones are allowed at the dining table.” | |
| Motivation | Perceived benefits | Facilitator | “The results are very appealing; weight loss and energy are appealing.” “It gave my body some time to rest.” “It makes you aware of your eating habits and keep you accountable |
| Habit and emotional reinforcement | Facilitator | “Cutting out snacks at night made me feel so much better.” “I don’t sit down with a bowl of ice cream anymore.” | |
| Intervention support (coaching) | Facilitator | “The coaching was helpful… it helps form habits.” “I wouldn’t have been as consistent without talking to someone.” | |
| Low motivation | Barrier | “I was not extrinsically motivated, and I was not intrinsically motivated.” | |
| Behavior | Behavioral outcome | Facilitator | “I am going to continue doing this forever.” “Plan to continue but probably not so strict with it.” “Again, I may not make the full 16 h every day.” “This program made me change.” |
| Outcome | PNF+ (n = 23) | Healthy Diet (n = 10) | Mean Difference in Change from Baseline | 95% CI for Difference | p-Value | Effect Size (Cohen’s d) | ||
|---|---|---|---|---|---|---|---|---|
| Baseline Mean (SD) | Post-Intervention Mean (SD) | Baseline Mean (SD) | Post-Intervention Mean (SD) | |||||
| Body Weight (lbs.) | 197.5 (24.2) | 195.2 (25.7) | 220.3 (28.1) | 223.3 (29.5) | −2.7 | (−9.3, 3.9) | 0.41 | 0.31 |
| Body Mass Index (BMI) | 29.3 (2.9) | 29.1 (3.0) | 31.5 (5.6) | 31.6 (5.8) | −0.2 | (−0.9, 0.5) | 0.32 | 0.38 |
| FACIT-F | 43.6 (5.5) | 45.2 (5.3) | 42.5 (10.1) | 45.5 (11.2) | −1.4 | (−4.6, 1.8) | 0.56 | −0.25 |
| FACT-P | 121.3 (14.0) | 125.5 (12.0) | 121.1 (21.3) | 119.8 (22.6) | 5.5 | (−3.0, 14.0) | 0.10 | 0.72 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Wen, K.-Y.; Freedman, J.; Zarrabi, K.K.; Slamon, R.; Smith, R.; Liang, J.; Mille, P.; Tester, W.J.; Kelly, W. A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial. Nutrients 2026, 18, 1166. https://doi.org/10.3390/nu18071166
Wen K-Y, Freedman J, Zarrabi KK, Slamon R, Smith R, Liang J, Mille P, Tester WJ, Kelly W. A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial. Nutrients. 2026; 18(7):1166. https://doi.org/10.3390/nu18071166
Chicago/Turabian StyleWen, Kuang-Yi, Julianne Freedman, Kevin Kayvan Zarrabi, Rachel Slamon, Rita Smith, Jessica Liang, Patrick Mille, William J. Tester, and William Kelly. 2026. "A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial" Nutrients 18, no. 7: 1166. https://doi.org/10.3390/nu18071166
APA StyleWen, K.-Y., Freedman, J., Zarrabi, K. K., Slamon, R., Smith, R., Liang, J., Mille, P., Tester, W. J., & Kelly, W. (2026). A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial. Nutrients, 18(7), 1166. https://doi.org/10.3390/nu18071166

